AGP
CRL icon

Artia Global Partners’s Charles River Laboratories CRL Stock Holding History

Artia Global Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,305
Closed -$1.16M – 37
2024
Q4 		$1.16M Hold
6,305
– – 0.42% 33
2024
Q3 		$1.24M Sell
6,305
-600
-9% -$125K 0.34% 29
2024
Q2 		$1.43M Hold
6,905
– – 0.28% 32
2024
Q1 		$1.87M Hold
6,905
– – 0.38% 28
2023
Q4 		$1.63M Hold
6,905
– – 0.47% 22
2023
Q3 		$1.35M Hold
6,905
– – 0.56% 21
2023
Q2 		$1.45M Hold
6,905
– – 0.5% 29
2023
Q1 		$1.39M Buy
+6,905
New +$1.56M 0.52% 25

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Artia Global Partners's CRL Position: Q1 2025 in Review

Artia Global Partners sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 6,305 shares — an estimated $1.16M sold.

Artia Global Partners first reported a position in CRL in Q1 2023 and held it in 8 quarters. The position peaked at $1.87M in Q1 2024. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Artia Global Partners reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Artia Global Partners sold 6,305 Charles River Laboratories shares in Q1 2025, an estimated $1.16M.
  • Artia Global Partners first reported a position in Charles River Laboratories in Q1 2023 and held it in 8 quarters.
  • Artia Global Partners's Charles River Laboratories position peaked at $1.87M in Q1 2024.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Artia Global Partners's 13F filing for Q1 2025, filed 15 May 2025.